A series of platinum(II) complexes with the formulas Pt(diimine)(pip(2)NCNH(2))(L)(2+) [pip(2)NCNH(2)(+) = 2,6-bis(piperidiniummethyl)phenyl cation; L = Cl, Br, I, NCS, OCN, and NO(2); diimine = 1,10-phenanthroline (phen), 5-nitro-1,10-phenanthroline (NO(2)phen), and 5,5'-ditrifluoromethyl-2,2'-bipyridine (dtfmbpy)] were prepared by the treatment of Pt(pip(2)NCN)Cl with a silver(I) salt followed by the addition of the diimine and halide/pseudohalide under acidic conditions. Crystallographic data as well as (1)H NMR spectra establish that the metal center is bonded to a bidentate phenanthroline and a monodentate halide/pseudohalide. The pip(2)NCNH(2)(+) ligand with protonated piperidyl groups is monodentate and bonded to the platinum through the phenyl ring. Structural and spectroscopic data indicate that the halide/pseudohalide group (L(-)) and the metal center in Pt(phen)(pip(2)NCNH(2))(L)(2+) behave as Brønsted bases, forming intramolecular NH···L/NH···Pt interactions involving the piperidinium groups. A close examination of the 10 structures reported here reveals linear correlations between N-H···Pt/L angles and H···Pt/L distances. In most cases, the N-H bond is directed toward the Pt-L bond, thereby giving the appearance that the proton bridges the Pt and L groups. In contrast to observations for Pt(tpy)(pip(2)NCN)(+) (tpy = 2,2';6',2"-terpyridine), the electrochemical oxidation of deprotonated adducts, Pt(diimine)(L)(pip(2)NCN), is chemically and electrochemically irreversible.
No takes yet. Share an insight, caveat, or question.
Chatterjee et al. (2012) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: